Glucose Control and Incretin Replacement: Achieving Therapeutic Impact CME
Osama B. Hamdy, MD, PhD, FACE; Paul S. Jellinger, MD, MACE Author Information and Disclosures
Release Date: July 12, 2007; Valid for credit through July 12, 2008
| Physicians - maximum of 1.5 AMA PRA Category 1 Credit(s)™ for physicians |
 |
This activity was developed from the recorded transcript and slides of the accredited CME symposium titled "Glucose Control and Incretin Replacement: Achieving Therapeutic Impact," which took place in Philidelphia, PA on March 13, 2007.
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape, Joslin Diabetes Center, or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
Copyright © 2007 by Joslin Diabetes Center, Inc. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written consent of Joslin Diabetes Center is prohibited.
